NCT03204695View on ClinicalTrials.gov

WAVECREST Post Market Clinical Follow-Up (PMCF) Study

NATerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

June 14, 2018

Study Completion Date

June 14, 2018

Conditions
Non-valvular Atrial Fibrillation
Interventions
DEVICE

Percutaneous LAA Closure

LAA Closure with the WaveCrest LAA Occlusion System (study device)

DRUG

Anticoagulation or Clopidogrel

Subjects either continue on anticoagulation or receive clopidogrel

Trial Locations (1)

Unknown

OLV Hospital, Aalst

Sponsors

Lead Sponsor

Coherex Medical
All Listed Sponsors
lead

Coherex Medical

INDUSTRY